No Data
No Data
Convano: Confirmatory letter.
Convano: Interim report
Convano: Securities Report - 11th Fiscal Year (April 1, 2023 - March 31, 2024)
The Nikkei 250 index on the Tokyo Stock Exchange continued to rise, as the increase in biotech-related stocks stimulated investor confidence.
Tokyo Stock Exchange Growth Market Index 835.17 +10.18 / volume 161,370,000 shares / trading value 137.1 billion yen. Tokyo Stock Exchange Growth Market 250 index 647.30 +8.53 / volume 77,980,000 shares / trading value 85.7 billion yen. Today's growth market, the Tokyo Stock Exchange Growth Market Index rose for the fourth consecutive day, and the Tokyo Stock Exchange Growth Market 250 Index also rose. The number of rising stocks was 362, the number of declining stocks was 177, and the unchanged stocks were 42. The US stock market on the 24th was mixed. The Dow Jones Industrial Average fell 260.8 points.
Volume change rate ranking (13:00) - including Shinbio, Cringle, etc.
In the volume change rate ranking, by comparing the volume of the last 5 days average with the volume on the delivery day, you can understand the concerns of market participants such as trend of hunting. The top change rate of the volume: [As of 13:32 on June 24] (comparison of the last 5-day average volume) code => stock name => volume => 5-day average volume => volume change rate => stock price change rate <160A> As Partners 342600 46100 238.53% 0.1235%<4221> Okura Works ...
Chordia Therapeutics, Free, etc.
<190A> Chordia Therapeutics Co., Ltd. Nomura Spark Investment Co., Ltd. Shareholding Ratio: -% -> 7.71% Reporting Obligation Date: 2024/06/14 <190A> Chordia Therapeutics Co., Ltd. Kyoto University Innovation Capital Co., Ltd. Shareholding Ratio: -% -> 12.14% Reporting Obligation Date: 2024/06/14 <190A> Chordia Therapeutics Co.
No Data